Tag | Content |
---|---|
UniProt Accession | CHK1_HUMAN; O14757; |
Entrez ID | 1111 |
GenBank Protein ID | NM_001114121.2; NM_001114122.2; NM_001244846.1; NM_001274.5; NM_001330428.1; XM_017017146.1; |
GenBank Nucleotide ID | NP_001107593.1; NP_001107594.1; NP_001231775.1; NP_001265.2; NP_001317357.1; XP_016872635.1; |
Protein Name | Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) |
Gene Name | CHEK1; CHK1 |
Organism | Homo sapiens |
NCBI Taxa ID | 9606 |
Functional Description | Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. May also negatively regulate cell cycle progression during unperturbed cell cycles. This regulation is achieved by a number of mechanisms that together help to preserve the integrity of the genome. Recognizes the substrate consensus sequence [R-X-X-S/T]. Binds to and phosphorylates CDC25A, CDC25B and CDC25C. Phosphorylation of CDC25A at 'Ser-178' and 'Thr-507' and(view all) |
Sequence (Fasta) | MAVPFVEDWD LVQTLGEGAY GEVQLAVNRV TEEAVAVKIV DMKRAVDCPE NIKKEICINK 60 MLNHENVVKF YGHRREGNIQ YLFLEYCSGG ELFDRIEPDI GMPEPDAQRF FHQLMAGVVY 120 LHGIGITHRD IKPENLLLDE RDNLKISDFG LATVFRYNNR ERLLNKMCGT LPYVAPELLK 180 RREFHAEPVD VWSCGIVLTA MLAGELPWDQ PSDSCQEYSD WKEKKTYLNP WKKIDSAPLA 240 LLHKILVENP SARITIPDIK KDRWYNKPLK KGAKRPRVTS GGVSESPSGF SKHIQSNLDF 300 SPVNSASSEE NVKYSSSQPE PRTGLSLWDT SPSYIDKLVQ GISFSQPTCP DHMLLNSQLL 360 GTPGSSQNPW QRLVKRMTRF FTKLDADKSY QCLKETCEKL GYQWKKSCMN QVTISTTDRR 420 NNKLIFKVNL LEMDDKILVD FRLSKGDGLE FKRHFLKIKG KLIDIVSSQK IWLPAT 477 |
|
Database | Annotation |
---|---|
CTD (Curated) (count: 2) | MESH:D001943
; Breast Neoplasms MESH:D011123 ; Polyploidy |
DisGeNet (Curated) (count: 3) | C0032578; Polyploidy
C0036341; Schizophrenia C1458155; Mammary Neoplasms |
GWASdb (count: 2) | rs3731399; Schizophrenia; schizophrenia
rs3731440; Type 2 diabetes; type 2 diabetes mellitus |
PTM | Modification Sites |
---|---|
Phosphorylation (count: 29) (view all) | 279 GAKRPRVTSGGVSES dbPAF
280 AKRPRVTSGGVSESP dbPAF 284 RVTSGGVSESPSGFS dbPAF 286 TSGGVSESPSGFSKH dbPAF 288 GGVSESPSGFSKHIQ dbPAF 291 SESPSGFSKHIQSNL dbPAF |
Acetylation (count: 5) | 166 NRERLLNKMCGTLPY PLMD
405 EKLGYQWKKSCMNQV PLMD 461 HFLKIKGKLIDIVSS PLMD 53 VDCPENIKKEICINK PLMD 54 DCPENIKKEICINKM PLMD |
Ubiquitination (count: 22) (view all) | 132 GITHRDIKPENLLLD PLMD
145 LDERDNLKISDFGLA PLMD 166 NRERLLNKMCGTLPY PLMD 180 YVAPELLKRREFHAE PLMD 225 YSDWKEKKTYLNPWK PLMD 233 TYLNPWKKIDSAPLA PLMD |
Network | Interaction | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A | B | Source | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|